支架再狭窄后Absorb生物可吸收血管支架的完全生物吸收 - Suppr

Fully bioresorption of an Absorb bioresorbable vascular scaffold after scaffold restenosis.

作者信息

Goncalves-Ramírez Luis R, Gutiérrez Hipólito, Rojas Paol, Cortés Carlos, Serrador Ana, Ramos Benigno, Toro Jairo, Amat-Santos Ignacio J, San Román José A

机构信息

CIBERCV, Hospital Clínico Universitario, Valladolid, Spain.

Institute of Heart Sciences, Hospital Clínico Universitario, Valladolid, Spain.

出版信息

Cardiol J. 2019;26(2):209-211. doi: 10.5603/CJ.2019.0047.

DOI:10.5603/CJ.2019.0047

PMID:31032876

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8086657/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dbf0/8086657/33c7dbe50071/cardj-26-2-209f1.jpg

相似文献

Fully bioresorption of an Absorb bioresorbable vascular scaffold after scaffold restenosis.

Cardiol J. 2019;26(2):209-211. doi: 10.5603/CJ.2019.0047.

First reported use of drug-coated balloon for bioresorbable in-scaffold restenosis.

Catheter Cardiovasc Interv. 2017 Mar 1;89(4):676-678. doi: 10.1002/ccd.26803. Epub 2016 Sep 21.

Restenosis of Coronary Bioresorbable Vascular Scaffolds.

Rev Esp Cardiol (Engl Ed). 2017 Jul;70(7):527-531. doi: 10.1016/j.rec.2017.02.024. Epub 2017 Mar 9.

Late Malapposition After Bare-Metal Stent, But Not Bioresorbable Scaffold: Insights on Intraindividual Heterogeneity in Plaque and Device Response.

J Invasive Cardiol. 2015 Aug;27(8):E171-2.

Full scaffold jacket for spontaneous coronary artery dissection of left anterior descending artery with magnesium reabsorbable scaffolds: 1 year follow-up.

Coron Artery Dis. 2020 Aug;31(5):481-484. doi: 10.1097/MCA.0000000000000836.

First serial assessment at 6 months and 2 years of the second generation of absorb everolimus-eluting bioresorbable vascular scaffold: a multi-imaging modality study.

Circ Cardiovasc Interv. 2012 Oct;5(5):620-32. doi: 10.1161/CIRCINTERVENTIONS.112.971549. Epub 2012 Oct 9.

Late-acquired scaffold malapposition and discontinuity that may be attributable to pathological coronary ectasia: Insights from optical coherence tomography.

Int J Cardiol. 2015;186:136-8. doi: 10.1016/j.ijcard.2015.03.235. Epub 2015 Mar 18.

Long-term intravascular follow-up of coronary bifurcation treatment with Absorb bioresorbable vascular scaffold.

Acta Cardiol. 2018 Aug;73(4):413-414. doi: 10.1080/00015385.2017.1420439. Epub 2017 Dec 25.

The Absorb Limits.

J Invasive Cardiol. 2016 Oct;28(10):E122-E123.

Neointimal proliferation is associated with clinical restenosis 2 years after fully bioresorbable vascular scaffold implantation.

Circ Cardiovasc Imaging. 2014 Jul;7(4):755-7. doi: 10.1161/CIRCIMAGING.114.001727.

引用本文的文献

Coronary Vasoreactivity after Complete Bioresorption of Absorb BVS at 5-Year Follow-Up.

Arq Bras Cardiol. 2021 Feb;116(2 suppl 1):8-11. doi: 10.36660/abc.20190783.

本文引用的文献

Implantation of bioresorbable scaffolds under guidance of optical coherence tomography: Feasibility and pilot clinical results of a systematic protocol.

Cardiol J. 2018;25(4):443-458. doi: 10.5603/CJ.a2018.0055. Epub 2018 May 18.

Report of an ESC-EAPCI Task Force on the evaluation and use of bioresorbable scaffolds for percutaneous coronary intervention: executive summary.

EuroIntervention. 2018 Jan 20;13(13):1574-1586. doi: 10.4244/EIJ20170912-01.

Bioresorbable Scaffolds versus Metallic Stents in Routine PCI.

N Engl J Med. 2017 Jun 15;376(24):2319-2328. doi: 10.1056/NEJMoa1614954. Epub 2017 Mar 29.

Change in lumen eccentricity and asymmetry after treatment with Absorb bioresorbable vascular scaffolds in the ABSORB cohort B trial: a five-year serial optical coherence tomography imaging study.

EuroIntervention. 2017 Apr 7;12(18):e2244-e2252. doi: 10.4244/EIJ-D-16-00740.

1-year outcomes with the Absorb bioresorbable scaffold in patients with coronary artery disease: a patient-level, pooled meta-analysis.

Lancet. 2016 Mar 26;387(10025):1277-89. doi: 10.1016/S0140-6736(15)01039-9. Epub 2016 Jan 27.

Absorb bioresorbable vascular scaffold versus everolimus-eluting metallic stent in ST-segment elevation myocardial infarction: 1-year results of a propensity score matching comparison: the BVS-EXAMINATION Study (bioresorbable vascular scaffold-a clinical evaluation of everolimus eluting coronary stents in the treatment of patients with ST-segment elevation myocardial infarction).

JACC Cardiovasc Interv. 2015 Jan;8(1 Pt B):189-197. doi: 10.1016/j.jcin.2014.10.005.

OCT assessment of the long-term vascular healing response 5 years after everolimus-eluting bioresorbable vascular scaffold.

J Am Coll Cardiol. 2014 Dec 9;64(22):2343-56. doi: 10.1016/j.jacc.2014.09.029. Epub 2014 Dec 1.

A bioresorbable everolimus-eluting scaffold versus a metallic everolimus-eluting stent for ischaemic heart disease caused by de-novo native coronary artery lesions (ABSORB II): an interim 1-year analysis of clinical and procedural secondary outcomes from a randomised controlled trial.

Lancet. 2015 Jan 3;385(9962):43-54. doi: 10.1016/S0140-6736(14)61455-0. Epub 2014 Sep 14.

Five-year clinical and functional multislice computed tomography angiographic results after coronary implantation of the fully resorbable polymeric everolimus-eluting scaffold in patients with de novo coronary artery disease: the ABSORB cohort A trial.

JACC Cardiovasc Interv. 2013 Oct;6(10):999-1009. doi: 10.1016/j.jcin.2013.05.017.

A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods.

Lancet. 2009 Mar 14;373(9667):897-910. doi: 10.1016/S0140-6736(09)60325-1.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Fully bioresorption of an Absorb bioresorbable vascular scaffold after scaffold restenosis.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献

本文引用的文献